Cargando…
Preclinical evaluation of recombinant human IFNα(2)b-containing magnetoliposomes for treating hepatocellular carcinoma
Magnetoliposomes are phospholipid vesicles encapsulating magnetic nanoparticles that can be used to encapsulate therapeutic drugs for delivery into specific organs. Herein, we developed magnetoliposomes containing recombinant human IFNα(2)b, designated as MIL, and evaluated this combination’s biolog...
Autores principales: | Ye, Hui, Tong, Jiansong, Wu, Jianzhang, Xu, Xia, Wu, Shenjie, Tan, Botao, Shi, Mengjing, Wang, Jianguang, Zhao, Weibo, Jiang, Heng, Jin, Sha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184408/ https://www.ncbi.nlm.nih.gov/pubmed/25288882 http://dx.doi.org/10.2147/IJN.S67228 |
Ejemplares similares
-
Combination of gemcitabine-containing magnetoliposome and oxaliplatin-containing magnetoliposome in breast cancer treatment: A possible mechanism with potential for clinical application
por: Ye, Hui, et al.
Publicado: (2016) -
Magnetoliposomes containing magnesium ferrite nanoparticles as nanocarriers for the model drug curcumin
por: Cardoso, Beatriz D., et al.
Publicado: (2018) -
Magnetoliposomes Containing Calcium Ferrite Nanoparticles for Applications in Breast Cancer Therapy
por: Pereira, Daniela S. M., et al.
Publicado: (2019) -
Magnetoliposomes as model for signal transmission
por: Barreto, G. R., et al.
Publicado: (2019) -
Effects of DC Magnetic Fields on Magnetoliposomes
por: Nuñez-Magos, L., et al.
Publicado: (2021)